• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Safety

  • Print
  • Share
  • E-mail

Clomid (clomiphene citrate) tablets

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – October 2012

Summary View

 

WARNINGS

  • Visual disorders, ovarian hyperstimulation syndrome, and urticaria updated
 

PRECAUTIONS

  • Visual disorders, ovarian hyperstimulation syndrome, and urticaria updated
 

ADVERSE REACTIONS

Postmarketing Adverse Events
  • Specific congenital abnormality terms
  • Visual disorders, ovarian hyperstimulation syndrome, and urticaria updated